149 related articles for article (PubMed ID: 17699212)
1. Update on cyclooxygenase-2 inhibitors.
Harris RC; Breyer MD
Clin J Am Soc Nephrol; 2006 Mar; 1(2):236-45. PubMed ID: 17699212
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and the kidney.
Harris RC
J Cardiovasc Pharmacol; 2006; 47 Suppl 1():S37-42. PubMed ID: 16785827
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
5. [Nonsteroidal antirheumatics and the kidney].
Galesić K; Morović-Vergles J; Jelaković B
Reumatizam; 2005; 52(2):61-6. PubMed ID: 16689132
[TBL] [Abstract][Full Text] [Related]
6. Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
Kahvecioglu S; Dilek K; Akdag I; Gullulu M; Demircan C; Ersoy A; Yurtkuran M
Nephrology (Carlton); 2006 Jun; 11(3):232-7. PubMed ID: 16756637
[TBL] [Abstract][Full Text] [Related]
7. The search for new COX-2 inhibitors: a review of 2002 - 2008 patents.
Ramalho TC; Rocha M; da Cunha EF; Freitas MP
Expert Opin Ther Pat; 2009 Sep; 19(9):1193-228. PubMed ID: 19563267
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.
Cheng HF; Harris RC
Curr Pharm Des; 2005; 11(14):1795-804. PubMed ID: 15892676
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenases, the kidney, and hypertension.
Cheng HF; Harris RC
Hypertension; 2004 Mar; 43(3):525-30. PubMed ID: 14732722
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of cyclooxygenase-2 inhibitors.
Brophy JM
Curr Opin Gastroenterol; 2007 Nov; 23(6):617-24. PubMed ID: 17906437
[TBL] [Abstract][Full Text] [Related]
11. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
Aneja A; Farkouh ME
Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408
[TBL] [Abstract][Full Text] [Related]
12. Does cyclooxygenase-2 affect blood pressure?
Cheng HF; Harris RC
Curr Hypertens Rep; 2003 Feb; 5(1):87-92. PubMed ID: 12530941
[TBL] [Abstract][Full Text] [Related]
13. An update on cyclooxygenase-2 expression and metabolites in the kidney.
Harris RC
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):64-9. PubMed ID: 18090672
[TBL] [Abstract][Full Text] [Related]
14. The autonomic nervous system and pressure-natriuresis in cardiovascular-renal interactions in response to salt.
Johns EJ
Clin Auton Res; 2002 Aug; 12(4):256-63. PubMed ID: 12357279
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Willette RN; Eybye ME; Olzinski AR; Behm DJ; Aiyar N; Maniscalco K; Bentley RG; Coatney RW; Zhao S; Westfall TD; Doe CP
J Pharmacol Exp Ther; 2009 Sep; 330(3):964-70. PubMed ID: 19556450
[TBL] [Abstract][Full Text] [Related]
16. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
Arber N
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibitors and cardiovascular risk.
Funk CD; FitzGerald GA
J Cardiovasc Pharmacol; 2007 Nov; 50(5):470-9. PubMed ID: 18030055
[TBL] [Abstract][Full Text] [Related]
20. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
